Shree Ssd Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 03-07-2024
- Paid Up Capital ₹ 0.50 M
as on 03-07-2024
- Company Age 12 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.20 Cr
as on 03-07-2024
- Revenue 18.44%
(FY 2021)
- Profit -247.26%
(FY 2021)
- Ebitda -18.98%
(FY 2021)
- Net Worth -15.73%
(FY 2021)
- Total Assets 37.75%
(FY 2021)
About Shree Ssd Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹2.20 Cr.
Jagdish Daswani, Jaiprakash Tekchandani, Manish Daswani, and One other member serve as directors at the Company.
- CIN/LLPIN
U74120MH2012PTC234219
- Company No.
234219
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Aug 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Shree Ssd Pharma?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jagdish Daswani  | Director | 06-Aug-2012 | Current |
| Jaiprakash Tekchandani | Director | 06-Aug-2012 | Current |
| Manish Daswani | Director | 06-Aug-2012 | Current |
| Shrichand Daswani | Director | 06-Aug-2012 | Current |
Financial Performance of Shree Ssd Pharma.
Shree Ssd Pharma Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 18.44% increase. The company also saw a substantial fall in profitability, with a 247.26% decrease in profit. The company's net worth observed a substantial decline by a decrease of 15.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shree Ssd Pharma?
In 2021, Shree Ssd Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ssd Medical Supplies Private LimitedActive 9 years 4 monthsJagdish Daswani, Jaiprakash Tekchandani and 1 more are mutual person
Shree Signify Exim Private LimitedActive 9 years 8 monthsJaiprakash Tekchandani and Manish Daswani are mutual person
Ssd Green Future LlpActive 1 year 12 daysJagdish Daswani, Jaiprakash Tekchandani and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 13 Mar 2021 | ₹2.20 Cr | Open |
How Many Employees Work at Shree Ssd Pharma?
Unlock and access historical data on people associated with Shree Ssd Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shree Ssd Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shree Ssd Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
